• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ONYX FRONTIER; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ONYX FRONTIER; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number ONYXNG45012UX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Myocardial Infarction (1969); Stenosis (2263); Thrombosis/Thrombus (4440); Insufficient Information (4580)
Event Date 01/01/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the index procedure two onyx frontier drug eluting stents were implanted in the left main coronary artery (lmca) and in the left anterior descending artery (lad).During the index procedure 6 nc euphora balloons and 1 launcher guide catheter were also used.There were no issues noted with the nc euphora balloons and launcher guide catheter used during the index procedure.Approximately 7 months post procedure the patient suffered a spontaneous st segment elevation myocardial infarction (stemi).The patient presented to the hospital with 3 days of stuttering substernal chest pressure that became constant, radiating from the right to left shoulder.The ae was associated with a myocardial infarction (mi) and was classified as a spontaneous mi in the territory of the target vessel.It was stated that the mi was related to to definite stent thrombosis in both stents.In stent restenosis was also noted in both stents.The event was treated with a clinically driven target lesion revascularization of the lmca and the circumflex artery (cx).During the re-vascularization, 1 onyx frontier stent, 3 nc euphora balloons,1 euphora balloon and 1 launcher guide catheter were used.The patient is recovering.The patient was taking dual antiplatelet therapy within 24 hours prior to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX FRONTIER
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18552442
MDR Text Key333359862
Report Number9612164-2024-00346
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier00763000511722
UDI-Public00763000511722
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberONYXNG45012UX
Device Catalogue NumberONYXNG45012UX
Device Lot Number0011427826
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2024
Date Device Manufactured09/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
Patient SexMale
Patient Weight96 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-